tirzepatide lily direct Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity FDA approves tirzepatide, Eli Lilly's

The US Food and Drug Administration (FDA) has approved 6 medications for long-term use, including orlistat, phentermine plus topiramate, naltrexone plus bupropion, subcutaneous liraglutide, subcutaneous semaglutide, and subcutaneous tirzepatide

Our physicians will review your health history, current medications, and treatment goals to determine whether semaglutide, tirzepatide, or a different approach makes the most sense, and walk you through what to expect before any treatment begins

The menace of obesity to depression and anxiety prevalence

But here is what many people miss

Patients who understand this early are the ones who transition faster into next-phase strategies instead of staying stuck trying to push harder on the same approach

2.5mg dose side effects Common (30-40% of users): Mild nausea (first 2-3 days) Slight fatigue Reduced appetite Management : Eat smaller meals Avoid greasy foods Stay hydrated Ginger for nausea Duration : Usually resolves within 3-5 days 5mg dose side effects Common (40-50%): Moderate nausea (dose day + 1-2 days after) Constipation Mild headache Management : Anti-nausea medication (Zofran) if needed Increase fiber and water Walk after meals Electrolyte supplementation 7.5-10mg dose side effects Common (30-40%): Nausea (body adapted by now, less severe) Constipation (more common) Fatigue on injection day Management : Miralax or magnesium for constipation Inject evening instead of morning Meal timing strategies Lower fat intake 12.5-15mg dose side effects Common (20-30%): Similar to 10mg but slightly more intense GI slowdown Occasional reflux Management : Smaller, more frequent meals Avoid late-night eating Antacids if needed Consider staying at 10mg if intolerable Read our peptide safety guide for complete information